HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-11-28FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for RETROVIR (Zidovudine) filed by ViiV Healthcare Company.
-
FDA approval · 2017-11-28FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for RETROVIR (zidovudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2017-11-28FDA Approved: RETROVIR — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for RETROVIR (Zidovudine) from ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
A terminated clinical trial reports development of resistance mutations in HIV-infected pregnant women after perinatal antiretroviral therap…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Enhancing Housing First Programs With a Social Network Substance Use Intervention [NA]
A RAND-sponsored trial evaluating a social network–based substance use intervention within Housing First programs has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Reality Check: An HIV Risk Reduction Serial Drama [NA]
Completed clinical trial evaluating an HIV risk reduction serial drama as an intervention.
-
FDA approval · 2017-11-22FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for ISENTRESS (raltegravir) from Merck Sharp & Dohme LLC.
-
FDA approval · 2017-11-22FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Isentress (raltegravir) from Merck Sharp & Dohme LLC.
-
FDA approval · 2017-11-22FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved Merck's supplemental application for Isentress (raltegravir) to modify its labeling related to HIV-1 infection.
-
FDA approval · 2017-11-22FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) from Gilead Sci…
-
FDA approval · 2017-11-21FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company.
-
FDA approval · 2017-11-21FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for TRIUMEQ (abacavir sulfate, dolutegravir sodium, lamivudine) from ViiV Healthcare, resulting …
-
FDA approval · 2017-11-21FDA Approved: JULUCA — Original Application (ViiV Healthcare Company)
FDA approved JULUCA (dolutegravir and rilpivirine) as an oral fixed-dose combination for HIV-1 infection in adults who are virologically sup…
-
FDA approval · 2017-11-21FDA Approved: ABACAVIR — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA's generic abacavir under an original ANDA for use in HIV-1 infection as part of combination antiretroviral therap…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Impact of CMV Status on HIV Viral Load Decay
A completed clinical trial investigating whether cytomegalovirus (CMV) status influences the rate of HIV viral load decay.
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Dolutegravir Impact on Residual Replication [Phase 4]
Phase 4 trial results evaluate dolutegravir's impact on residual HIV replication.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection [Phase 2, Phase 3]
A multi-part open-label study evaluated ABT-450/r/ABT-267 with or without ABT-333 and ribavirin in adults with genotype 1 or 4 HCV, with or …
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET) [Phase 2]
Phase 2 dose-finding trial of GSK2248761 in antiretroviral therapy-naive HIV patients was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART [Phase 1]
Phase 1 safety and immunogenicity study of a plasmid DNA Prime and MVA Boost HIV vaccine in ART-treated HIV-1 infected adults has been compl…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine [Phase 4]
Phase 4 trial update evaluating the clinical efficacy of the fixed-dose combination of emtricitabine, tenofovir, and nevirapine in HIV.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) [Phase 2]
Phase II safety study and open-label demonstration of pre-exposure prophylaxis (PrEP) use among 15–17-year-old young men who have sex with m…
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Feasibility of Telerehabilitation in HIV-patients [NA]
A completed study evaluating the feasibility of telerehabilitation for people living with HIV.
-
CLINICAL_TRIALS trial_result · 2017-11-07Clinical Trial Update: Online Social Networking for HIV Prevention [NA]
This clinical trial update reports completed results for an online social networking intervention aimed at HIV prevention.
-
CLINICAL_TRIALS research · 2017-11-07Clinical Trial Update: Risk Assessment of Long-Haul Truck Drivers
This clinical trial update reports a completed study assessing risk factors among long-haul truck drivers across several infectious and meta…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Cohort of HIV Associated Lymphomas
A completed cohort study investigating HIV-associated lymphomas in people with HIV, sponsored by ANRS and Emerging Infectious Diseases.